265
Participants
Start Date
March 20, 2014
Primary Completion Date
May 11, 2016
Study Completion Date
April 13, 2017
Herpes Zoster vaccine GSK1437173A
2 doses administered intramuscularly (IM) in the deltoid region of the non-dominant arm.
Placebo
2 doses administered intramuscularly (IM) in the deltoid region of the non-dominant arm.
GSK Investigational Site, Taipei
GSK Investigational Site, Keelung
GSK Investigational Site, Taoyuan District
GSK Investigational Site, Taichung
GSK Investigational Site, Kaohsiung City
GSK Investigational Site, Brussels
GSK Investigational Site, Brussels
GSK Investigational Site, Leuven
GSK Investigational Site, Ghent
GSK Investigational Site, Córdoba
GSK Investigational Site, Genoa
GSK Investigational Site, Milan
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Treviso
GSK Investigational Site, Santander
GSK Investigational Site, Seville
GSK Investigational Site, Parma
GSK Investigational Site, Barakaldo (Vizcaya)
GSK Investigational Site, Siena
GSK Investigational Site, Edmonton
GSK Investigational Site, Halifax
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Hradec Králové
GSK Investigational Site, Helsinki
GSK Investigational Site, Panama City
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, L'Hospitalet de Llobregat
Lead Sponsor
GlaxoSmithKline
INDUSTRY